Allan Collins
Direktor/Vorstandsmitglied bei SEASTAR MEDICAL HOLDING CORPORATION
Vermögen: 27 725 $ am 30.04.2024
Profil
Allan J.
Collins is currently the Director at SeaStar Medical, Inc. and an Independent Director at Seastar Medical Holding Corp.
He previously worked as the Director at United States Renal Data System, President at Advances In Kidney Disease & Health, Chief Medical Officer at NxStage Medical, Inc., and President at National Kidney Foundation.
Dr. Collins completed his undergraduate degree at Wayne State University (Michigan).
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
16.04.2024 | 57 402 ( 0,09% ) | 27 725 $ | 30.04.2024 |
Aktive Positionen von Allan Collins
Unternehmen | Position | Beginn |
---|---|---|
SEASTAR MEDICAL HOLDING CORPORATION | Direktor/Vorstandsmitglied | 01.01.2021 |
SeaStar Medical, Inc.
SeaStar Medical, Inc. Information Technology ServicesTechnology Services Seastar Medical, Inc. manufactures and supplies medical devices. It offers medical device that cures inflammation-based diseases and conditions. The company was founded by James P. Sherblom in July 2007 and is headquartered in Denver, CO. | Direktor/Vorstandsmitglied | 08.01.2021 |
Ehemalige bekannte Positionen von Allan Collins
Unternehmen | Position | Ende |
---|---|---|
National Kidney Foundation | Präsident | - |
NXSTAGE MEDICAL, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Advances In Kidney Disease & Health
Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Advances In Kidney Disease & Health provides awareness on kidney and urinary tract diseases. The organization helps to increase the availability of all organs for transplantation. The company was founded in 1950 and is headquartered in New York, NY. | Präsident | - |
Ausbildung von Allan Collins
Wayne State University (Michigan) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SEASTAR MEDICAL HOLDING CORPORATION | Health Technology |
Private Unternehmen | 4 |
---|---|
Advances In Kidney Disease & Health
Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Advances In Kidney Disease & Health provides awareness on kidney and urinary tract diseases. The organization helps to increase the availability of all organs for transplantation. The company was founded in 1950 and is headquartered in New York, NY. | Commercial Services |
NxStage Medical, Inc.
NxStage Medical, Inc. Medical SpecialtiesHealth Technology NxStage Medical, Inc. is a medical technology company, which develops, manufactures, and markets products for the treatment of ESRD and acute kidney failure. It operates through the following business segments: System One, In-Center, and Services. The System One segment engages in the sale and rental of the System One and PureFlow SL equipment and the sale of disposable products in the home and critical care markets. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers and needles for apheresis. The Services segment includes revenues from dialysis services provided to patients at its recently opened NxStage Kidney Care dialysis centers. The company was founded by Jeffrey H. Burbank in December 1998 and is headquartered in Waltham, MA. | Health Technology |
SeaStar Medical, Inc.
SeaStar Medical, Inc. Information Technology ServicesTechnology Services Seastar Medical, Inc. manufactures and supplies medical devices. It offers medical device that cures inflammation-based diseases and conditions. The company was founded by James P. Sherblom in July 2007 and is headquartered in Denver, CO. | Technology Services |
National Kidney Foundation | Commercial Services |